Bilal Arif - Jun 21, 2024 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Signature
/s/ Ryan Brown as Attorney-in-Fact for Bilal Arif
Stock symbol
SRPT
Transactions as of
Jun 21, 2024
Transactions value $
-$2,305,124
Form type
4
Date filed
6/25/2024, 08:00 PM
Previous filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Options Exercise +6.25K +24.78% 31.5K Jun 21, 2024 Direct F1
transaction SRPT Common Stock Tax liability -$387K -2.35K -7.47% $164.64 29.1K Jun 24, 2024 Direct F2
transaction SRPT Common Stock Sale -$906K -5.58K -19.16% $162.31 23.5K Jun 24, 2024 Direct F3, F4
transaction SRPT Common Stock Sale -$173K -1.06K -4.48% $163.83 22.5K Jun 24, 2024 Direct F3, F5
transaction SRPT Common Stock Sale -$49.4K -300 -1.33% $164.61 22.2K Jun 24, 2024 Direct F3, F6
transaction SRPT Common Stock Sale -$116K -700 -3.16% $166.10 21.5K Jun 24, 2024 Direct F3, F7
transaction SRPT Common Stock Sale -$37.4K -224 -1.04% $167.13 21.3K Jun 24, 2024 Direct F3, F8
transaction SRPT Common Stock Sale -$636K -3.9K -18.33% $163.23 17.4K Jun 25, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Performance Stock Units Award $0 +6.25K $0.00 6.25K Jun 21, 2024 Common Stock 6.25K Direct F1
transaction SRPT Performance Stock Units Options Exercise $0 -6.25K -100% $0.00* 0 Jun 21, 2024 Common Stock 6.25K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the number of shares earned and vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU.
F2 Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 1, 2024.
F3 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.25 to $163.21, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.35 to $164.18, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.38 to $164.91, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $165.69 to $166.44, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $166.91 to $167.36, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.